Secondary Logo

Journal Logo

October 1994 - Volume 16 - Issue 3
pp: 175-250

PDF Only


Potential to Involve Multiple Effector Cells with Human Recombinant Interleukin-2 and Antiganglioside Monoclonal Antibodies in a Canine Malignant Melanoma Immunotherapy Model

Helfand, Stuart C.; Soergel, Steve A.; Donner, Robin L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(3):188-197, October 1994.

Intraperitoneal Adoptive Immunotherapy of Ovarian Carcinoma with Tumor-Infiltrating Lymphocytes and Low-Dose Recombinant Interleukin-2: A Pilot Trial

Freedman, Ralph S.; Edwards, Creighton L.; Kavanagh, John J.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(3):198-210, October 1994.

Phase II Trials of High-Dose Interleukin-2 and Lymphokine-Activated Killer Cells in Advanced Breast Carcinoma and Carcinoma of the Lung, Ovary, and Pancreas and Other Tumors

Sparano, Joseph A.; Fisher, Richard I.; Weiss, Geoffrey R.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(3):216-223, October 1994.

Bilateral Adrenal Hemorrhage and Adrenal Insufficiency in a Patient with Lymphomatous Adrenal Infiltration Following Administration of a Fusion Toxin (DAB486Interleukin-2)

Cohen, Roger; Jaffe, Elaine S.; Stetler-Stevenson, Mary-Alice; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(3):229-233, October 1994.


PDF Only


Show: